Vaxxinity Issues Shareholder Letter
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Vaxxinity Inc (VAXX)
Vaxxinity Inc stock price live, this page displays OTC VAXX stock exchange data. View the VAXX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Vaxxinity Inc real time stock price chart below.
What Is the Vaxxinity Inc Stock Price Today?
The Vaxxinity Inc stock price today is 0.0001.
What Is the Stock Symbol for Vaxxinity Inc?
The stock symbol for Vaxxinity Inc is ""VAXX.""
What Stock Exchange Does Vaxxinity Inc Trade On?
Vaxxinity Inc is listed and trades on the OTC Markets stock exchange.
Is Vaxxinity Inc a Good Stock to Buy?
Determining whether Vaxxinity Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VAXX quote. (ISIN: US92244V1044)
What Is the Vaxxinity Inc Stock Price Today?
The Vaxxinity Inc stock price today is 0.0001.
What Is the Stock Symbol for Vaxxinity Inc?
The stock symbol for Vaxxinity Inc is ""VAXX.""
What Stock Exchange Does Vaxxinity Inc Trade On?
Vaxxinity Inc is listed and trades on the OTC Markets stock exchange.
Is Vaxxinity Inc a Good Stock to Buy?
Determining whether Vaxxinity Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VAXX quote. (ISIN: US92244V1044)
OTC Markets
Currency in USD
0.0001
0.0000(0.00%)
Closed·
Fair Value
An estimate of a Vaxxinity's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0001
0.0001
52 wk Range
0.0001
0.1900
VAXX Scorecard
Full Analysis
Stock has taken a big hit over the last week
Trading near 52-week Low
More Info
Fair Value
An estimate of a Vaxxinity's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.00010.0001
52 wk Range
0.00010.1900
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VAXX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Vaxxinity's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
- Vaxxinity to voluntarily delist from Nasdaq
- Investing.com
- Vaxxinity Issues Shareholder Letter
- Investing.com
- Vaxxinity to voluntarily delist from Nasdaq
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Vaxxinity Inc Company Profile
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States. Its product pipeline comprises UB-311, which is in phase 2 clinical trial that targets toxic forms of aggregated amyloid-b in the brain to fight alzheimer’s disease; UB-312, which is in phase 1 clinical trial that targets toxic forms of aggregated a-synuclein in the brain to fight parkinson’s disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy; and VXX-301, which is in preclinical trial, an anti-tau product candidate for various neurodegenerative conditions, including alzheimer’s disease, traumatic brain injury, and chronic traumatic encephalopathy. It also develops VXX-401, that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; UB-313, which is in Phase 1 clinical trial targets calcitonin gene-related peptide to fight migraines; and UB-612, neutralizes the SARS-CoV-2 virus and is in phase 3 clinical trial. It has a collaboration agreement with the University of Florida, University of Central Florida, and the University of Southampton. The company was incorporated in 2021 and is headquartered in Merritt Island, Florida.
Compare VAXX to Peers and Sector
Metrics to compare | VAXX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVAXXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −3.4x | −0.5x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.0x | 2.0x | 2.6x | |
Price / LTM Sales | 0.0x | 9.7x | 3.2x | |
Upside (Analyst Target) | 0.0% | 205.7% | 45.7% | |
Fair Value Upside | Unlock | 15.1% | 8.6% | Unlock |
Earnings
Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Vaxxinity Trade On?
Vaxxinity is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Vaxxinity?
The stock symbol for Vaxxinity is "VAXX."
What Is the Vaxxinity Market Cap?
As of today, Vaxxinity market cap is 12.67K.
What Is Vaxxinity's Earnings Per Share (TTM)?
The Vaxxinity EPS (TTM) is -0.45.
When Is the Next Vaxxinity Earnings Date?
Vaxxinity will release its next earnings report on 05 Aug 2025.
From a Technical Analysis Perspective, Is VAXX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Vaxxinity Stock Split?
Vaxxinity has split 0 times.
How Many Employees Does Vaxxinity Have?
Vaxxinity has 61 employees.
What is the current trading status of Vaxxinity (VAXX)?
As of 02 Aug 2025, Vaxxinity (VAXX) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.19.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.